Hepatology

1. ZHANG F, Zhao Y, Bian L, Wang X, et al
   IL1beta Signaling Mediates the Interaction Between Hepatitis B and C Viruses.
   Hepatology. 2025 Sep 12. doi: 10.1097/HEP.0000000000001525.
   

   >> Share

   
   
2. DASARATHY S, Tu W, Welch N, Gawrieh S, et al
   Natural history and development of a novel composite endpoint in patients with alcohol-associated Hepatitis: Data from a prospective multicenter study.
   Hepatology. 2025 Sep 9. doi: 10.1097/HEP.0000000000001513.
   

   >> Share

   
   

   
   J Immunol

3. LI X, Sun W, Wang Q, Zhang H, et al
   Type 1 regulatory cells suppress T-cell cytotoxicity to alleviate liver injury during acute hepatitis B virus infection in mice.
   J Immunol. 2025 Sep 9:vkaf229. doi: 10.1093.
   

   >> Share

   
   

   
   J Med Virol

4. YAN B, Lv J, Feng Y, Yin W, et al
   Epidemiology and Genetic Surveillance of Human Hepatitis E Virus Infections in Shandong Province, Eastern China, 2019-2023.
   J Med Virol. 2025;97:e70595.
   

   >> Share

   
   

   
   J Viral Hepat

5. LUONG CL, Ellett LK, Pratt N, Staff K, et al
   Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024.
   J Viral Hepat. 2025;32:e70082.
   

   >> Share

   
   
6. NATOUR RT, Haimi M, Hazan R, Saadi T, et al
   Reduced Predictive Performance of the FIB-4 Index in Chronic Hepatitis B Patients With Concurrent Metabolic Dysfunction-Associated Liver Disease.
   J Viral Hepat. 2025;32:e70071.
   

   >> Share

   
   
7. YING X, Ng N, Reidy D, Azari J, et al
   Prescriber Specialty Involvement in Medicare Patients With Chronic Hepatitis B.
   J Viral Hepat. 2025;32:e70070.
   

   >> Share

   
   
8. XIAO J, Zhang X, Mao X, Lai S, et al
   Efficacy and Safety of Velpatasvir Plus Sofosbuvir With or Without Ribavirin in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-Analysis.
   J Viral Hepat. 2025;32:e70078.
   

   >> Share

   
   
9. TAO X, Yu W, Yan Q, Han G, et al
   Age Modifies the Association Between HBV DNA Levels and Liver Dysfunction Risk During Pregnancy.
   J Viral Hepat. 2025;32:e70074.
   

   >> Share

   
   
10. ABU-DAYYEH I, Chemaitelly H, Al Tibi A, Ghunaim M, et al
    Hepatitis B Virus in Jordan: Prevalence, Incidence and Clearance From Cross-Sectional and Cohort Studies.
    J Viral Hepat. 2025;32:e70075.
    

    >> Share

    
    
11. MOHAREB AM, Ezaz G, Kim AY, Freedberg KA, et al
    Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure.
    J Viral Hepat. 2025;32:e70079.
    

    >> Share

    
    
12. AHAD M, Moussa D, Wallace J, Wade AJ, et al
    Knowledge and Perceptions of Hepatitis B in Immigrant Populations: A Systematic Review and Thematic Synthesis of Qualitative Research.
    J Viral Hepat. 2025;32:e70069.
    

    >> Share

    
    
13. CONWAY A, Grebely J, Treloar C, Matthews S, et al
    Policymaker Perspectives on the Role of Health Systems in Sustainable Hepatitis C Point-Of-Care Testing in Australia.
    J Viral Hepat. 2025;32:e70080.
    

    >> Share

    
    

    
    J Virol

14. PIRACHA ZZ, Kwon H, Saeed U, Kim J, et al
    Retraction for Piracha et al., "Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3beta/beta-Catenin Signaling Pathway".
    J Virol. 2025 Sep 12:e0118625. doi: 10.1128/jvi.01186.
    

    >> Share

    
    
15. SAEED U, Kim J, Piracha ZZ, Kwon H, et al
    Retraction for Saeed et al., "Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner".
    J Virol. 2025 Sep 12:e0118725. doi: 10.1128/jvi.01187.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

16. LAZARO-MARTIN B, Tarancon-Diez L, Camino Lopez M, Alonso R, et al
    A Prospective Cohort Study of Hepatitis B Virus Vaccination in Pediatric Heart Transplant Recipients: Cellular and Humoral Immune Responses and the Role of Innate Immunity.
    Pediatr Infect Dis J. 2025 Sep 11. doi: 10.1097/INF.0000000000004958.
    

    >> Share

    
    

    
    PLoS One

17. HAN L, Bi L, Li X
    The diagnostic value of decreased levels of inflammatory markers for the state of hepatitis C virus (HCV) infection.
    PLoS One. 2025;20:e0332105.
    

    >> Share

    
    
18. WAGI CR, McDowell R, Wright A, Egan KL, et al
    Navigating Hepatitis C care: Knowledge gaps and access barriers among young women who inject drugs in rural Appalachia.
    PLoS One. 2025;20:e0331849.
    

    >> Share

    
    
19. SHENGELAIA L, Anderson EJ, Butsashvili M, Gulbiani L, et al
    Hepatitis C virus reinfection among people who inject drugs in the country of Georgia and injection-related risk factors: Implications for HCV elimination in the EECA region.
    PLoS One. 2025;20:e0330764.
    

    >> Share

    
    

    
    PLoS Pathog

20. SCHWOERER MP, Carver S, Lin AE, Liu J, et al
    Receptor transporter protein 4 (RTP4)-mediated repression of hepatitis C virus replication in mouse cells.
    PLoS Pathog. 2025;21:e1013412.
    

    >> Share

    
    

    
    Virology

21. ZHU Q, Yang Y, Zhou H
    Novel insights into the role of cGAS-STING signaling in HBV infection.
    Virology. 2025;611:110639.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share